Wenjia Sun

1.3k total citations
39 papers, 973 citations indexed

About

Wenjia Sun is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Wenjia Sun has authored 39 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Immunology and 11 papers in Oncology. Recurrent topics in Wenjia Sun's work include Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Bacterial Infections and Vaccines (4 papers). Wenjia Sun is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Bacterial Infections and Vaccines (4 papers). Wenjia Sun collaborates with scholars based in China, Singapore and United States. Wenjia Sun's co-authors include Weiwei Huang, Xu Yang, Cunbao Liu, Yanbing Ma, Yufeng Yao, Hongmei Bai, Yang Li, Qiong Long, Xiaojie Chu and Shijie Wang and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wenjia Sun

39 papers receiving 959 citations

Peers

Countries citing papers authored by Wenjia Sun

Since Specialization

Citations

This map shows the geographic impact of Wenjia Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjia Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjia Sun more than expected).

Fields of papers citing papers by Wenjia Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjia Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjia Sun. The network helps show where Wenjia Sun may publish in the future.

Co-authorship network of co-authors of Wenjia Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjia Sun. A scholar is included among the top collaborators of Wenjia Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjia Sun. Wenjia Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD161 ⁺ CD127 ⁺ CD8 ⁺ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus 2024 ·OncoImmunology ·Jingjing Qu, (unknown), (unknown), Qian Shen, Lijun Chen, Wenjia Sun, Bo Wang, (unknown), Li Wu, Hong Zhou, Jianya Zhou, Jianying Zhou, (unknown), (unknown)	4
2	Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy 2023 ·Nature Communications ·Yaxin Shi, Zhibin Guo, Qiang Fu, Xinyuan Shen, Zhongming Zhang, Wenjia Sun, Jinqiang Wang, Junliang Sun, Zizhu Zhang, Tong Liu, Zhen Gu, Zhibo Liu	50
3	[Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer]. 2023 ·SHILAP Revista de lepidopterología ·(unknown), He Cao, Jing Zheng, Wenjia Sun, Jianya Zhou	1
4	Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response 2022 ·Nanomedicine Nanotechnology Biology and Medicine ·Qiong Long, Ying Yang, Mengli Yang, Hongmei Bai, Wenjia Sun, Xu Yang, Weiwei Huang, (unknown), Yanbing Ma	4
5	Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients 2021 ·Cancer Immunology Immunotherapy ·Xi Chen, (unknown), Yan‐Ping Zhu, Zhang Bao, Qing Wang, Rong Liu, Wenjia Sun, Haiwei Du, Jing Lin, Bing Yu, (unknown), Jianya Zhou, Jianying Zhou	31
6	First-in-Human Phase 1 Study of ES-072, an Oral Mutant-Selective EGFR T790M Inhibitor, in Non–Small-Cell Lung Cancer 2020 ·Clinical Lung Cancer ·Jing Zheng, Lisha Shen, Nan Jiang, Yan‐Ping Zhu, Lihua Wu, He Cao, Wenjia Sun, Jianya Zhou, Jianying Zhou, (unknown), (unknown)	3
7	Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics 2020 ·Journal of Cancer ·He Cao, Jing Zhao, (unknown), Wenjia Sun, (unknown), Jianya Zhou, Jianying Zhou	10
8	Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer 2019 ·Acta Biomaterialia ·(unknown), Hongxian Liu, Xiaojie Chu, (unknown), Weiwei Huang, Cunbao Liu, Xu Yang, Wenjia Sun, Hongmei Bai, Yanbing Ma	18
9	<p>Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor</p> 2019 ·International Journal of Nanomedicine ·(unknown), Qishu Zhang, Hongmei Bai, Weiwei Huang, (unknown), Chao Ye, Wenjia Sun, Yanbing Ma	17
10	Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model 2016 ·International Journal of Nanomedicine ·Yanbing Ma, Xiaojie Chu, Yang Li, Qiong Long, Ye Xia, Yufeng Yao, Wenjia Sun, Weiwei Huang, Yang Xu, Cunbao Liu	31
11	Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection 2016 ·Scientific Reports ·Weiwei Huang, Shijie Wang, Yufeng Yao, Ye Xia, Yang Xu, Kui Li, (unknown), Cunbao Liu, Wenjia Sun, Hongmei Bai, Xiaojie Chu, Yang Li, Yanbing Ma	101
12	Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii 2016 ·Scientific Reports ·Weiwei Huang, Yufeng Yao, Shijie Wang, Ye Xia, Xu Yang, Qiong Long, Wenjia Sun, Cunbao Liu, Yang Li, Xiaojie Chu, Hongmei Bai, (unknown), Yanbing Ma	99
13	Effect of Nano-SiO_2 Modified by Block Oligomer on the Crystallization Property of PET 2015 ·Cailiao daobao ·Wenjia Sun	1
14	OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections 2015 ·Vaccine ·Weiwei Huang, Shijie Wang, Yufeng Yao, Ye Xia, Xu Yang, Qiong Long, Wenjia Sun, Cunbao Liu, Yang Li, Yanbing Ma	63
15	5-Hydroxymethylcytosine-Mediated DNA Demethylation in Stem Cells and Development 2014 ·Stem Cells and Development ·Wenjia Sun, Min‐Xin Guan, Xuekun Li	20
16	Virus-like particles presenting interleukin-33 molecules 2014 ·Human Vaccines & Immunotherapeutics ·Qiong Long, Weiwei Huang, Yufeng Yao, Xu Yang, Wenjia Sun, (unknown), Yang Li, Xiaojie Chu, Cunbao Liu, Zhikang Peng, Yanbing Ma	18
17	Diverse expression levels of two codon-optimized genes that encode human papilloma virus type 16 major protein L1 in Hansenula polymorpha 2014 ·Biotechnology Letters ·Cunbao Liu, Xu Yang, Yufeng Yao, Weiwei Huang, Wenjia Sun, Yanbing Ma	5
18	Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models 2014 ·PLoS ONE ·Weiwei Huang, Yufeng Yao, Qiong Long, Xu Yang, Wenjia Sun, Cunbao Liu, (unknown), Yang Li, Xiaojie Chu, Bin Chen, Yanbing Ma	102
19	The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC 2011 ·Diagnostic Microbiology and Infectious Disease ·Hongbin Chen, Yudong Liu, Wenjia Sun, Minjun Chen, Hui Wang	16
20	The molecular characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus in China 2009 ·Zhonghua jianyan yixue zazhi ·Hongbin Chen, Hui Wang, Wenjia Sun, (unknown), Minjun Chen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact